Literature DB >> 33706723

Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review.

Lesley-Ann Lynnath Cannon1, Kelechi Elizabeth Oladimeji2, Daniel Ter Goon2.   

Abstract

BACKGROUND: Drug-resistant TB (DR-TB) remains a public health concern due to the high morbidity and mortality rates from the disease. The DR-TB is a multifaceted illness with expensive treatment regimens, toxic medications and most often the long duration of treatment constitutes a substantial financial burden on both infected patients and the health system. Despite significant research advances in the diagnosis and treatment, there is a paucity of synthesized evidence on how socio-economic factors are associated with DR-TB. This review aims to address this gap by synthesizing available evidence and data on the common socio-economic drivers of DR-TB infection in Africa.
METHODS: A systematic search was conducted on PUBMED and Google Scholar databases from January 2011 to January 2020 using Joanna Briggs Institute's scoping review approach. An updated search was conducted on 21 September 2020. The eligibility criteria only included systematic reviews and studies with quantitative research methods (cross-sectional, case-control, cohort, and randomized-control trials). Studies conducted in Africa and focusing on socio-economic factors influencing DR-TB burden in African countries were also considered. Data was extracted from all the studies that met the eligibility criteria based on the study's objectives.
RESULTS: Out of the 154 articles that were retrieved for review, 20 abstracts of these articles met all the eligibility criteria. Of the 20 articles, 17 quantitative and 3 reviews. Two additional articles were found eligible, following the updated search. The following themes were identified as major findings: Social and economic drivers associated with DR-TB. Substance abuse of which, stigma and discrimination were the prominent social drivers. Economic drivers included poverty, financial constraints because of job loss, loss of productive time during hospital admission and treatment costs.
CONCLUSION: This review has highlighted which socio-economic factors contribute to DR- TB This is relevant to assist DR-TB management program and TB stakeholders in different settings to address identified socio-economic gaps and to reduce its negative impact on the programmatic management of DR TB. Therefore, redirecting strategies with more focus on socio-economic empowerment of DR-TB patients could be one of the innovative solutions to reduce the spread and eliminate DR-TB in Africa.

Entities:  

Keywords:  Africa; Drug-resistant TB; Socio-economic drivers

Year:  2021        PMID: 33706723      PMCID: PMC7953648          DOI: 10.1186/s12889-021-10267-0

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  32 in total

1.  Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.

Authors:  E du Toit; S B Squire; R Dunbar; R Machekano; J Madan; N Beyers; P Naidoo
Journal:  Int J Tuberc Lung Dis       Date:  2015-08       Impact factor: 2.373

Review 2.  Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review.

Authors:  Francesco Di Gennaro; Damiano Pizzol; Bonifacio Cebola; Brendon Stubbs; Laura Monno; Annalisa Saracino; Claudio Luchini; Marco Solmi; Giulia Segafredo; Giovanni Putoto; Nicola Veronese
Journal:  Tuberculosis (Edinb)       Date:  2017-01-11       Impact factor: 3.131

3.  Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.

Authors:  L Ramma; H Cox; L Wilkinson; N Foster; L Cunnama; A Vassall; E Sinanovic
Journal:  Int J Tuberc Lung Dis       Date:  2015-12       Impact factor: 2.373

4.  Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia.

Authors:  Girma Mulisa; Tilaye Workneh; Niguse Hordofa; Mohamed Suaudi; Gemeda Abebe; Godana Jarso
Journal:  Int J Infect Dis       Date:  2015-09-12       Impact factor: 3.623

5.  How affordable is TB care? Findings from a nationwide TB patient cost survey in Ghana.

Authors:  Debora Pedrazzoli; Andrew Siroka; Delia Boccia; Frank Bonsu; Kenneth Nartey; Rein Houben; Josephine Borghi
Journal:  Trop Med Int Health       Date:  2018-06-25       Impact factor: 2.622

6.  Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.

Authors:  Sizulu Moyo; Helen S Cox; Jennifer Hughes; Johnny Daniels; Leigh Synman; Virginia De Azevedo; Amir Shroufi; Vivian Cox; Gilles van Cutsem
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

7.  The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.

Authors:  Susan van den Hof; David Collins; Firdaus Hafidz; Demissew Beyene; Aigul Tursynbayeva; Edine Tiemersma
Journal:  BMC Infect Dis       Date:  2016-09-05       Impact factor: 3.090

8.  Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia.

Authors:  Kefyalew Addis Alene; Kerri Viney; Emma S McBryde; Archie C A Clements
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

9.  TB treatment initiation and adherence in a South African community influenced more by perceptions than by knowledge of tuberculosis.

Authors:  Jane M Cramm; Harry J M Finkenflügel; Valerie Møller; Anna P Nieboer
Journal:  BMC Public Health       Date:  2010-02-17       Impact factor: 3.295

10.  Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.

Authors:  Feleke Mekonnen; Belay Tessema; Feleke Moges; Aschalew Gelaw; Setegn Eshetie; Gemechu Kumera
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.